The medical therapy of hemorrhagic complications following coronary artery bypass grafting.
Rossi
C M
CM
Bianchi
W
W
Zaccarini
P
P
Ohnmeiss
H
H
D007611:Aprotinin / Q000627:therapeutic use*; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D006801:Humans
D007611:Aprotinin